David Hayes, an analyst from Jefferies, maintained the Buy rating on Haleon PLC (HLN – Research Report). The associated price target remains the same with p460.00.
David Hayes has given his Buy rating due to a combination of factors including the resilience of Haleon PLC in the face of industry concerns. Despite worries about potential weaknesses in the respiratory segment and declining consumer trends in North America, Haleon has demonstrated strong performance. The company achieved over 3% organic sales growth in the first quarter, with volume growth exceeding 1%, meeting expectations and maintaining its full-year guidance.
Hayes also highlights the company’s commitment to accelerating its organic sales growth sequentially, which positions it to outperform its peers. This strategic focus, along with the company’s ability to counter industry challenges, underpins the positive outlook and Buy rating for Haleon’s stock.
According to TipRanks, Hayes is ranked #3196 out of 9371 analysts.